Baker Ellis Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Baker Ellis Asset Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$256K	Hold	4,450	–	–	0.03%	226
2026 Q1	$270K	Sell	4,450 -80	-2%	-$4.66K	0.03%	219
2025 Q4	$244K	Sell	4,530 -600	-12%	-$28.9K	0.03%	229
2025 Q3	$231K	Sell	5,130 -100	-2%	-$4.67K	0.03%	224
2025 Q2	$242K	Sell	5,230 -500	-9%	-$24.5K	0.03%	199
2025 Q1	$349K	Hold	5,730	–	–	0.05%	171
2024 Q4	$324K	Sell	5,730 -100	-2%	-$5.59K	0.05%	173
2024 Q3	$302K	Sell	5,830 -100	-2%	-$4.69K	0.04%	186
2024 Q2	$246K	Sell	5,930 -200	-3%	-$8.95K	0.04%	188
2024 Q1	$332K	Sell	6,130 -400	-6%	-$20.4K	0.05%	170
2023 Q4	$335K	Sell	6,530 -1,300	-17%	-$68.2K	0.05%	166
2023 Q3	$454K	Sell	7,830 -266	-3%	-$16.3K	0.08%	138
2023 Q2	$518K	Hold	8,096	–	–	0.09%	133
2023 Q1	$561K	Sell	8,096 -507	-6%	-$35.8K	0.1%	127
2022 Q4	$619K	Hold	8,603	–	–	0.12%	117
2022 Q3	$612K	Buy	8,603 +400	+5%	+$29K	0.13%	114
2022 Q2	$632K	Buy	8,203 +507	+7%	+$38.6K	0.13%	118
2022 Q1	$562K	Hold	7,696	–	–	0.1%	129
2021 Q4	$480K	Hold	7,696	–	–	0.08%	136
2021 Q3	$439K	Sell	7,696 -350	-4%	-$23.1K	0.08%	143
2021 Q2	$538K	Buy	8,046 +334	+4%	+$21.8K	0.11%	119
2021 Q1	$487K	Sell	7,712 -666	-8%	-$41.4K	0.11%	122
2020 Q4	$520K	Buy	8,378 +146	+2%	+$8.98K	0.12%	112
2020 Q3	$496K	Sell	8,232 -302	-4%	-$18.2K	0.14%	110
2020 Q2	$502K	Sell	8,534 -238	-3%	-$14.2K	0.15%	108
2020 Q1	$489K	Hold	8,772	–	–	0.18%	100
2019 Q4	$563K	Sell	8,772 -17,537	-67%	-$1M	0.16%	105
2019 Q3	$1.33M	Sell	26,309 -1,100	-4%	-$51.7K	0.35%	74
2019 Q2	$1.24M	Sell	27,409 -250	-0.9%	-$11.6K	0.33%	78
2019 Q1	$1.32M	Sell	27,659 -500	-2%	-$24.9K	0.37%	76
2018 Q4	$1.46M	Sell	28,159 -2,613	-8%	-$140K	0.44%	65
2018 Q3	$1.91M	Sell	30,772 -600	-2%	-$35.6K	0.49%	60
2018 Q2	$1.74M	Sell	31,372 -1,530	-5%	-$82.6K	0.46%	68
2018 Q1	$2.08M	Sell	32,902 -300	-0.9%	-$19.3K	0.55%	55
2017 Q4	$2.04M	Sell	33,202 -150	-0.4%	-$9.38K	0.51%	57
2017 Q3	$2.13M	Sell	33,352 -100	-0.3%	-$5.84K	0.56%	48
2017 Q2	$1.86M	Buy	33,452 +38	+0.1%	+$2.07K	0.51%	57
2017 Q1	$1.82M	Buy	33,414 +81	+0.2%	+$4.44K	0.52%	53
2016 Q4	$1.95M	Sell	33,333 -1,355	-4%	-$74.1K	0.57%	48
2016 Q3	$1.87M	Buy	34,688 +681	+2%	+$43.7K	0.56%	53
2016 Q2	$2.5M	Hold	34,007	–	–	0.78%	30
2016 Q1	$2.17M	Buy	34,007 +300	+0.9%	+$18.9K	0.72%	36
2015 Q4	$2.32M	Buy	33,707 +300	+0.9%	+$19.8K	0.8%	31
2015 Q3	$1.98M	Buy	33,407 +254	+0.8%	+$16.1K	0.71%	36
2015 Q2	$2.21M	Sell	33,153 -900	-3%	-$59.3K	0.74%	33
2015 Q1	$2.2M	Buy	34,053 +200	+0.6%	+$12.5K	0.7%	36
2014 Q4	$2M	Buy	33,853 +200	+0.6%	+$11.3K	0.67%	37
2014 Q3	$1.72M	Hold	33,653	–	–	0.6%	46
2014 Q2	$1.63M	Buy	33,653 +176	+0.5%	+$8.67K	0.56%	51
2014 Q1	$1.74M	Sell	33,477 -600	-2%	-$31.9K	0.6%	46
2013 Q4	$1.81M	Buy	34,077 +200	+0.6%	+$10.2K	0.63%	42
2013 Q3	$1.57M	Buy	33,877 +450	+1%	+$19.8K	0.59%	46
2013 Q2	$1.49M	Buy	+33,427	New	+$1.45M	0.59%	47

Other funds holding BMY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

ETC

Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Baker Ellis Asset Management's BMY Position: Q2 2026 in Review

Baker Ellis Asset Management held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 4,450 shares worth $256K. The position accounts for 0.03% of the portfolio, ranked #226.

Baker Ellis Asset Management first reported a position in BMY in Q2 2013 and has held it in 53 quarters since. The position peaked at $2.5M in Q2 2016. 878 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Baker Ellis Asset Management held 4,450 shares of Bristol-Myers Squibb worth $256K as of Q2 2026.
Baker Ellis Asset Management left its Bristol-Myers Squibb share count unchanged in Q2 2026.
Bristol-Myers Squibb made up 0.03% of Baker Ellis Asset Management's portfolio in Q2 2026, its #226 holding.
Baker Ellis Asset Management first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 53 quarters since.
Baker Ellis Asset Management's Bristol-Myers Squibb position peaked at $2.5M in Q2 2016.
878 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Baker Ellis Asset Management's 13F filing for Q2 2026, filed 23 Jul 2026.